Suraksha Diagnostic Ltd’s IPO shares made their stock market debut today, December 6, 2024, listing at a discount compared to the issue price. The shares were listed at ₹437 on the BSE and ₹438 on the NSE, compared to the issue price of ₹441. This resulted in a per-lot loss of ₹136 on the BSE and ₹102 on the NSE for retail investors.
IPO Details:
- Issue Price: ₹441
- Retail Lot Size: 34 shares
- Listing Price:
- BSE: ₹437
- NSE: ₹438
- Loss Per Lot:
- BSE: ₹136
- NSE: ₹102
Suraksha Diagnostic Ltd had launched its IPO between November 29 and December 3, priced in the range of ₹420–₹441 per share. The IPO received a moderate response, being subscribed 1.27 times, with 1.70 crore shares bid against 1.34 crore shares on offer.
The issue, an Offer for Sale (OFS) of 1.92 crore equity shares, allowed the company to raise ₹846.25 crore at the upper end of the price band.
Key Dates and Listing Details:
- IPO Opening Date: November 29, 2024
- IPO Closing Date: December 3, 2024
- IPO Allotment Finalization: December 4, 2024
- Listing Date: December 6, 2024
- Trading Group: B Group of Securities (as per BSE notice)
Suraksha Diagnostic’s shares were a part of the Special Pre-open Session (SPOS) today and became available for trading from 10:00 AM.
Despite its modest listing performance, Suraksha Diagnostic Ltd’s IPO reflects ongoing investor interest in the healthcare and diagnostic sector, which continues to draw attention due to its essential services and growth potential in India.
